SMD Rise PCL

SMD Rise PCL EBITDA Growth YoY

The Year-over-Year EBITDA Growth of SMD Rise PCL (SMD100.BK) as of Oct 19, 2026 is -73.54 %. In the previous year, Year-over-Year EBITDA Growth was -20.10 % — a change of 265.86% (lower).

EBITDA Growth YoY

-73.54 %

YoY

265.86%

Last updated:

Year-over-Year EBITDA Growth of SMD Rise PCL is 2025 -73.54 % . Year-over-Year EBITDA Growth of SMD Rise PCL was 2024 -20.10 % . It decreases by 265.86% lower compared to the previous year.

The SMD Rise PCL EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
4.30 THB
Jan 1, 2019
33.54 THB
Jan 1, 2020
18.80 THB
Jan 1, 2021
238.41 THB
Jan 1, 2022
-8.42 THB
Jan 1, 2023
-70.93 THB
Jan 1, 2024
-20.10 THB
Jan 1, 2025
-73.54 THB
The SMD Rise PCL EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-73.54 %+265.86%
-20.10 %-71.66%
-70.93 %+742.47%
-8.42 %-103.53%
238.41 %+1,168.00%
18.80 %-43.95%
33.54 %+679.25%
4.30 %-129.83%
-14.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL, listed on the Stock Exchange of Thailand with ticker SMD100.BK and ISIN THA320A10Y01, operates in the Health Care sector. The company was founded through an IPO on June 17, 2021. SMD Rise PCL is engaged in the distribution of medical devices and equipment, focusing on the import and distribution of medical supplies and services for medical equipment. The company specializes in respiratory system-related medical equipment, particularly offering sleep monitoring services and counseling on the use of positive pressure air compressors (CPAP) for treating obstructive sleep apnea (OSA). Its services target patients with sleep disorders, including snoring, obstructive sleep apnea, insomnia, and other conditions such as excessive daytime sleepiness, sleepwalking, bruxism, and leg twitching. Additionally, the company provides support for patients with high blood pressure, diabetes, and obesity. SMD Rise PCL's subsidiary is Saint Medical Trading Co., Ltd. The company's website is https://www.saintmed.com/. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

Year-over-Year EBITDA Growth of SMD Rise PCL is -73.54 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's SMD Rise PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — SMD Rise PCL

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — SMD Rise PCL